Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity

  1. Kasparas Petkevicius  Is a corresponding author
  2. Sam Virtue
  3. Guillaume Bidault
  4. Benjamin Jenkins
  5. Cankut Çubuk
  6. Cecilia Morgantini
  7. Myriam Aouadi
  8. Joaquin Dopazo
  9. Mireille Serlie
  10. Albert Koulman
  11. Antonio Vidal-Puig  Is a corresponding author
  1. University of Cambridge, United Kingdom
  2. Fundacion Progreso y Salud, Spain
  3. Karolinska Institute, Sweden
  4. Amsterdam University Medical Center, Netherlands

Abstract

White adipose tissue (WAT) inflammation contributes to the development of insulin resistance in obesity. While the role of adipose tissue macrophage (ATM) pro-inflammatory signalling in the development of insulin resistance has been established, it is less clear how WAT inflammation is initiated. Here, we show that ATMs isolated from obese mice and humans exhibit markers of increased rate of de novo phosphatidylcholine (PC) biosynthesis. Macrophage-specific knockout of phosphocholine cytidylyltransferase A (CCTa), the rate-limiting enzyme of de novo PC biosynthesis pathway, alleviated obesity-induced WAT inflammation and insulin resistance. Mechanistically, CCTa-deficient macrophages showed reduced ER stress and inflammation in response to palmitate. Surprisingly, this was not due to lower exogenous palmitate incorporation into cellular PCs. Instead, CCTa-null macrophages had lower membrane PC turnover, leading to elevated membrane polyunsaturated fatty acid levels that negated the pro-inflammatory effects of palmitate. Our results reveal a causal link between obesity-associated increase in de novo PC synthesis, accelerated PC turnover and pro-inflammatory activation of ATMs.

Data availability

We are submitting raw source data excel file for LC-MS lipidomics of Pcyt1a-deficient BMDMs, in both palmitate-treated and basal states (containing peak areas for each lipid species normalized to peak areas of respective internal standards) as Figure 6-source data 1.ATM microarray dataset (GSE36669) used in Figure 1 is already published and referenced in this manuscript.We are also submitting a list of differentially expressed genes detected by RNAseq in the eWAT of ob/ob bone marrow transplant mice, with a log (Fold change), log (CPM) and p value indicated for each gene as Supplementary file 2b.We have uploaded raw RNA sequencing data of liver macrophages isolated from WT and ob/ob mice in the NCBI database, under the following accession number: PRJNA541224.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Kasparas Petkevicius

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    kp416@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  2. Sam Virtue

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Guillaume Bidault

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Benjamin Jenkins

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Cankut Çubuk

    Clinical Bioinformatics Area, Fundacion Progreso y Salud, Sevilla, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4646-0849
  6. Cecilia Morgantini

    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3142-2508
  7. Myriam Aouadi

    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6256-7107
  8. Joaquin Dopazo

    Clinical Bioinformatics Area, Fundacion Progreso y Salud, Sevilla, Spain
    Competing interests
    The authors declare that no competing interests exist.
  9. Mireille Serlie

    Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  10. Albert Koulman

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Antonio Vidal-Puig

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    ajv22@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4220-9577

Funding

Wellcome (4-year PhD programme in Metabolic and Cardiovascular Disease)

  • Kasparas Petkevicius

British Heart Foundation (Programme Grant RG/18/7/33636)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Wellcome (Strategic Award)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Medical Research Council (MRC_MC_UU_12012/5)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Medical Research Council (MRC_MC_UU_12012/2)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Spanish Ministry of economy and competitiveness (SAF2017-88908-R)

  • Cankut Çubuk
  • Joaquin Dopazo

Swedish Research council (2015-03582)

  • Cecilia Morgantini
  • Myriam Aouadi

Strategic research program in Diabetes at Karolinska Institutet (M.A.)

  • Cecilia Morgantini
  • Myriam Aouadi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal protocols were conducted in accordance with the UK Home Office and Cambridge University ethical guidelines.

Human subjects: Human samples used for this work had been generated as part of another study, that has already been published and is referenced in our manuscript (de Weijer et al, 2013). This study had been conducted to the highest ethical standards, and the ethics statement is available in the published paper.

Copyright

© 2019, Petkevicius et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,074
    views
  • 608
    downloads
  • 49
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kasparas Petkevicius
  2. Sam Virtue
  3. Guillaume Bidault
  4. Benjamin Jenkins
  5. Cankut Çubuk
  6. Cecilia Morgantini
  7. Myriam Aouadi
  8. Joaquin Dopazo
  9. Mireille Serlie
  10. Albert Koulman
  11. Antonio Vidal-Puig
(2019)
Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity
eLife 8:e47990.
https://doi.org/10.7554/eLife.47990

Share this article

https://doi.org/10.7554/eLife.47990

Further reading

    1. Cell Biology
    Jessica Y Chotiner, N Adrian Leu ... P Jeremy Wang
    Research Article

    Meiotic progression requires coordinated assembly and disassembly of protein complexes involved in chromosome synapsis and meiotic recombination. Mouse TRIP13 and its ortholog Pch2 are instrumental in remodeling HORMA domain proteins. HORMAD proteins are associated with unsynapsed chromosome axes but depleted from the synaptonemal complex (SC) of synapsed homologs. Here we report that TRIP13 localizes to the synapsed SC in early pachytene spermatocytes and to telomeres throughout meiotic prophase I. Loss of TRIP13 leads to meiotic arrest and thus sterility in both sexes. Trip13-null meiocytes exhibit abnormal persistence of HORMAD1 and HOMRAD2 on synapsed SC and chromosome asynapsis that preferentially affects XY and centromeric ends. These major phenotypes are consistent with reported phenotypes of Trip13 hypomorph alleles. Trip13 heterozygous mice exhibit meiotic defects that are less severe than the Trip13-null mice, showing that TRIP13 is a dosage-sensitive regulator of meiosis. Localization of TRIP13 to the synapsed SC is independent of SC axial element proteins such as REC8 and SYCP2/SYCP3. Terminal FLAG-tagged TRIP13 proteins are functional and recapitulate the localization of native TRIP13 to SC and telomeres. Therefore, the evolutionarily conserved localization of TRIP13/Pch2 to the synapsed chromosomes provides an explanation for dissociation of HORMA domain proteins upon synapsis in diverse organisms.

    1. Cell Biology
    Johanna Odenwald, Bernardo Gabiatti ... Susanne Kramer
    Research Article

    Immunofluorescence localises proteins via fluorophore-labelled antibodies. However, some proteins evade detection due to antibody-accessibility issues or because they are naturally low abundant or antigen density is reduced by the imaging method. Here, we show that the fusion of the target protein to the biotin ligase TurboID and subsequent detection of biotinylation by fluorescent streptavidin offers an ‘all in one’ solution to these restrictions. For all proteins tested, the streptavidin signal was significantly stronger than an antibody signal, markedly improving the sensitivity of expansion microscopy and correlative light and electron microscopy. Importantly, proteins within phase-separated regions, such as the central channel of the nuclear pores, the nucleolus, or RNA granules, were readily detected with streptavidin, while most antibodies failed. When TurboID is used in tandem with an HA epitope tag, co-probing with streptavidin and anti-HA can map antibody-accessibility and we created such a map for the trypanosome nuclear pore. Lastly, we show that streptavidin imaging resolves dynamic, temporally, and spatially distinct sub-complexes and, in specific cases, reveals a history of dynamic protein interaction. In conclusion, streptavidin imaging has major advantages for the detection of lowly abundant or inaccessible proteins and in addition, provides information on protein interactions and biophysical environment.